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Abstract
Background: Transposed elements (TEs) are known to affect transcriptomes, because either new
exons are generated from intronic transposed elements (this is called exonization), or the element
inserts into the exon, leading to a new transcript. Several examples in the literature show that
isoforms generated by an exonization are specific to a certain tissue (for example the heart muscle)
or inflict a disease. Thus, exonizations can have negative effects for the transcriptome of an
organism.
Results: As we aimed at detecting other tissue- or tumor-specific isoforms in human and mouse
genomes which were generated through exonization of a transposed element, we designed the
automated analysis pipeline SERpredict (SER = Specific Exonized Retroelement) making use of
Bayesian Statistics. With this pipeline, we found several genes in which a transposed element
formed a tissue- or tumor-specific isoform.
Conclusion:  Our results show that SERpredict produces relevant results, demonstrating the
importance of transposed elements in shaping both the human and the mouse transcriptomes. The
effect of transposed elements on the human transcriptome is several times higher than the effect
on the mouse transcriptome, due to the contribution of the primate-specific Alu elements.
Background
Transposed elements (TEs) are sequences of DNA that can
move from one position to another in the genome. There
are two classes of transposed elements, the DNA trans-
posons and the retroelements. DNA transposons usually
move by cut and paste using the transposase enzyme. In
contrast, retroelements are genetic elements that integrate
in a genome via an RNA intermediate which is reverse-
transcribed to DNA. In mammals, almost half the genome
is comprised of TEs: around 45% of the human genome is
made up of them. This translates to millions of elements,
so that on average, every gene in our genome contains
about 3 transposed elements. Transposed elements com-
prise approximately 37% of the mouse genome.
The human and mouse genome sequences show that TEs
have played an important role in shaping the genomes
[1,2]. The human genome contains retroelements such as
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Alu, which is a short interspersed element (SINE), MIR
(mammalian interspersed repeat) as well as LINE-1 (L1),
LINE-2 (L2) and CR1 (L3). The last three of the given fam-
ilies of retroelements are termed long interspersed ele-
ments. In addition, the human genome contains LTR
elements such as MaLR (mammalian apparent LTR-retro-
transposon), ERVL and ERV1 (endogenous retroviruses)
as well as DNA transposons where common families are
MER1 and MER2. The mouse genome contains MIR ele-
ments as well as rodent-specific SINEs such as B1 (homol-
ogous to the left arm of the Alu), B2, B4 and ID as well as
LINEs such as L1, L2 and CR1. Similar to the human
genome, the mouse genome contains LTRs and DNA
transposons. With approximately 1 million copies, Alu is
the most frequently encountered TE in the human
genome. In mouse, B1 and L1 are the elements with the
highest number of copies (B1: 500,000 copies, L1:
800,000 copies).
Through splicing processes ("exonizations"), small pieces
of transposed elements can be inserted into mature
mRNAs. These exonizations are caused by motifs that
resemble consensus splice sites in both strands of the TEs
[3]. The transposed elements do not only contain these
splice sites but also polyadenylation sites, promoters,
enhancers and silencers. Therefore, they can add a variety
of functions to their targeted genes [4-6].
Mutations within intronic TEs may yield active splice sites
which can be used instead of the normal splice sites, lead-
ing to the partial exonization of the intronic TE. However,
the other TEs of the human and mouse genomes can be
exonized, too. In a previous study, Sela et al. [7] showed
that 1824 TEs are exonized in the human genome, of
which about 58% are Alus. In the mouse genome, 506
transposed elements are exonized, most of which are
either B1 or L1 elements (26% and 20%, respectively).
Thus, transposed elements can affect the transcriptome.
Either new exons are generated from intronic TEs (see Fig-
ure 1a (i)), or the TE inserts into the first or last exon of a
gene (Figure 1b (i)), leading to a new transcript [8]. In the
first case, the exonization can either generate an internal
cassette exon (Figure 1a (ii)), an alternative 3'splice site
(Figure 1a (iii)), an alternative 5'splice site (Figure 1a (iv))
or a constitutively spliced exon (Figure 1a (v)) [7,9]. In the
case of insertions into first or last exons, the insertions
cause either an elongation of the first/last exon (Figure 1b
(ii, iii)) or an activation of an alternative intron (Figure 1b
(iv)). For the exact number of occurrences of the different
events please refer to [7].
It has been previously reported that more than 5% of the
alternatively spliced exons in the human genome are Alu-
derived and that all Alu-derived exons are the result of
exonization of intronic sequences [8]. It can therefore be
supposed that genetic diseases can occur when an intronic
TE is constitutively or alternatively spliced into the mature
mRNA. Searching the literature indeed uncovers evidence
that Alu insertions cause genetic disorders [10-13].
Another effect of new exonizations is a potential tissue
specificity, in which an exon shows strong tissue regula-
tion [14]. An experimental verification of this mechanism
is described in a report on Alu de-novo insertion and sub-
sequent exonization within the dystrophin gene that cre-
ates a tissue-specific exon inflicting cardiomyopathy [15].
The effects of TE insertions Figure 1
The effects of TE insertions. a) (i) TE inserts into an intron of a gene. (ii-v) show the possible effects of this integration; (ii) 
alternatively exon is created, (iii) TE contributes alternative 5'splice site, (iv) TE contributes alternative 3'splice site, (v) TE cre-
ates a constitutively spliced exon. b) (i) TE inserts into the first or last exon of a gene. (ii – iv) show the possible effect of this 
integration: (ii, iii) enlargement of first or last exon, (iv) TE activates an alternative intron.
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Furthermore, since tumorous tissues have been shown to
adopt aberrant splicing patterns [16], there might be TE
exonizations that are potentially tumor-specific. The sur-
vivin gene is one example in which an Alu-generated
splice variant is tumor-specific [17].
For the detection of new tissue- or tumor-specific TE-con-
taining isoforms in human or mouse genes, we designed
and implemented SERpredict, an analysis pipeline making
use of Bayesian Statistics.
Implementation
SERpredict  is based on several databases: the Ensembl
database [18], the UCSC genome browser database [19],
dbEST [20], and EMBL [21]. How they are used and com-
bined is described in the following section.
Library classification
To obtain information about the tissue and the health sta-
tus of alternative splice forms of genes, the databases
dbEST [20] for expressed sequence tags (ESTs) and EMBL
[21] for mRNAs are used. These EST and mRNA sequence
databases provide information about tissue and tumor
sources. For dbEST, library information which include an
ID, the library name, the organism, the tissue and a more
detailed description is provided with each entry. For the
EMBL database, there are features termed "clone lib" and
"tissue type". However, this poses a problem since the
names of the tissues and tumors are not standardized
across the databases. For this reason, we extracted all the
EST and mRNA identifiers from the two databases dbEST
and EMBL, obtained the associated library information
and assigned a tissue category to every given tissue accord-
ing to [22] (see as well Additional file 1). Here, we used
key words to identify 52 different cell or tissue source cat-
egories, e.g., leukocyte is mapped to the category blood,
hippocampus is mapped to brain and so on. Furthermore,
either "tumor" or "normal" was added to each library,
using again keywords. All the information was then stored
in a locally installed MySQL database which is automati-
cally updated if one of the underlying databases is
updated. The "annotated" EST and mRNA sequences
obtained in this way were used to perform the statistical
analysis to determine whether a certain isoforms is tissue-
or tumor-specific.
Tissue and tumor specificity
The analysis for tissue or tumor specificity of a certain
alternative splice form can be done using the above
"annotated" EST and mRNA sequences. Therefore, all EST
and mRNA sequences which map the gene of interest have
to be extracted. To determine tissue or tumor specificity,
the extracted sequences have to be divided into two
groups reflecting the two isoforms of the gene. This is easy
in our special case of alternative isoforms because one of
the isoforms was generated by the exonization of an TE.
On the basis of this information, the ESTs and mRNAs are
separated into the groups "holding", when the TE is
present in the sequence of interest or "skipping", in cases
where the TE is not. Using the library classification terms
for the sequences, we then get four sets of distributions.
For each of those EST and mRNA sequences skipping the
TE as well as for those holding the TE, we obtain a tissue
and a source (tumor or normal) distribution.
Determining tissue or tumor specificity from these distri-
butions is not easy, because tissue and tumor source data
for EST or mRNA sequences are often incomplete and
inconsistent. For a certain gene there are often only a few
ESTs sequenced from a particular tissue covering the
exons of interest. We therefore have to cope with a poor
EST library coverage. Additionally, there are extremely dif-
ferent numbers of ESTs and mRNAs for the different tis-
sues, see Figure 2. This leads to a sampling bias problem.
To address these problems, statistical analysis is needed.
Furthermore, when dealing with tissue or tumor specifi-
city there is a problem with including ESTs from cell lines
into the analysis. Cell lines are often immortalized, and
the immortal lines obtained might not be a perfect repre-
sentation of the original cells in primary culture. For an
estimation how many of the ESTs originated from cell
lines, we checked the annotation in the dbEST database
and determined that only about 10% of the human and
mouse EST sequences were derived from cell lines.
Statistical analysis
To deal with the incomplete and inconsistent data, we
used a previously described Bayesian statistics approach
to identify tissue-specific exons [23] and to identify exons
showing deregulated splicing in tumors [24].
To identify tissue-specific exons, a tissue specificity score
(TS score) is computed. The confidence that a certain
splice variant is preferred in tissue T is calculated as a Baye-
sian posterior probability:
Here, θ1T represent the hidden frequency of a splice vari-
ant in a specific tissue T and obs stands for the number of
ESTs and mRNAs observed in tissue T. P(obs|θ1T) is calcu-
lated using a binomial distribution and P(θ1T) = 1 was
used as uninformative prior probability. In the same way,
the posterior probability that the same splice variant is
preferred in the pool of all other tissues ~ is computed.
The TS score for tissue T is then defined as the difference
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between the posterior probability for tissue T and the pos-
terior probability for the pool of all other tissues:
TS = 100 [P(θ1T > 50%|obs) - P (θ1~ > 50%|obs)]
(2)
Here, θ1~ is the frequency of a splice variant in the pool of
all other tissues ~. To assess the stability of the TS score
robustness values, rTS and rTS~ were calculated analogous
to the "jack-knife" resampling method. For more details,
please refer to [23].
To identify tumor-specific exons, a log-odd score (LOD
score) is calculated, giving the confidence that the fre-
quency of a splice variant in tumor tissue (θT) is higher
than the frequency of the splice variant in normal tissue
(θN):
The LOD score was calculated using direct numerical inte-
gration [24].
The criteria used for high-confidence of tissue specificity
were TS > 50, rTS > 0.9 and rTS ~ > 0.9 as described in [23].
A necessary condition for high confidence tissue specifi-
city was at least three EST observations of the mRNA con-
taining the exon in tissue T. As we wanted to have results
with high significance only, we changed the criteria for the
TS score to TS > 85 for our pipeline. For tumor specificity,
a log-odd score was calculated. As in [24], a log-odd score
above 2, equivalent to a p-value <0.01, was considered sig-
nificant.
LOD
P TN
P TN
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>
−>
log
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Pie chart of EST numbers Figure 2
Pie chart of EST numbers. Number of ESTs for the different tissues. This figure indicates the extremely different numbers 
of ESTs and mRNAs for the different tissues.
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Work flow in SERpredict
Using the information presented in the sections above, we
designed SERpredict to detect tissue- or tumor-specific iso-
forms, which were generated through the exonization of
transposed elements. The work flow is displayed in Figure
3.
Initially, the genomic information of the input sequence
is determined. Therefore, a Blast search [25] with
Ensembl_cdna [18] is performed. Utilizing the Ensembl
Application Programming Interface (API), the extracted
Ensembl gene identifier is then used to find all transcripts
of the gene and thereby all the different exons. If there is
no Blast hit matching the criteria (Identity > 95% and E-
value <10-3), an empty output is produced.
Subsequently, every extracted exon is screened for trans-
posed elements. This is done using the chrN_rmsk table of
the UCSC genome browser database [19], which maps the
positions of all TEs that have been found by RepeatMasker
[26] and the Repbase annotations [27,28] to the human
and mouse genomes, respectively. This approach is much
faster than using RepeatMasker directly.
Finally, for every such TE-containing exon, an analysis of
tissue or tumor specificity is performed as described in the
Section "Statistical Analysis". Subsequently, SERpredict
extracts all expressed sequence tags (ESTs) and mRNA
sequences from the UCSC genome browser database.
These are then divided into two groups as described in the
Section "Tissue and tumor specificity" and used as input
for the statistical analysis.
As output, SERpredict  returns a file with the following
information:
￿ Information about the genomic location: Ensembl gene
identifier, gene description, chromosome, strand, start
and end on genome, number of transcripts and corre-
sponding number of exons
￿ A graphical display of the alternative splice forms of the
gene
￿ Information about the repetitive elements: family, ID of
exon in which the TE is located, start and end of the TE
and the IDs of the transcript containing the TE-exon
￿ If observed: the tissue or tumor specificity of the TE-con-
taining exon
These results are provided as HTML for visual inspection
(see Figure 4) or can be downloaded as XML for easier
extraction of relevant results and for storage in private
databases.
Results and Discussion
All annotated genes of the human and mouse genomes
were screened for TE-containing exons. The number of
times the different transposed elements were exonized
(and fulfilled the condition of at least three EST observa-
tions of the mRNA containing the exon in tissue T) are
shown in Table 1 (for the human genome) and Table 2
(for the mouse genome).
The 859 human and 260 mouse TE-containing exons were
then analyzed for tissue or tumor specificity using SERpre-
dict. In the human exon list, we were able to identify 39
tissue-specifically spliced exons (see Table 3 for the exons
with tissue specificity (TS) score > 90). In the mouse exon
list, 11 exons showed tissue-specific splicing (see Table 4
for the exons with tissue specificity (TS) score > 90). In the
human genome, 18 exons belonged to Alu, 5 were L1
exons, 2 were L2 exons, 1 was an CR1 exon, 5 were MIR
exons, 4 were LTR exons and 4 were exons derived from
DNA transposons. The highest amount of tissue-specific
exonizations arises from the exonization of an Alu ele-
ment. The fact that the Alu is the most abundant trans-
posed element in the human genome and that it contains
potential splice sites makes it a much better-suited
sequence for the exonization process than other trans-
posed elements [7] and could be a reason for these results.
In mouse, 4 were B1 exons, 2 were B2 exons and 2 were
LTR exons. For B4, L2, MIR there was one exon each. The
higher amount of specific exonized B1 elements is consist-
ent with the fact that B1 derived from the same ancestral
origin as Alu. Still, B1 does not reach the same amount of
specific exonizations as Alu because the majority of exoni-
zations of Alu occur in the right arm of the Alu element
which is not present in B1. In contrast to the dimeric struc-
ture of the Alu element, B1 is a monomer.
We did not observe a tendency for specificity in any cer-
tain tissue in humans. In the mouse genome, interest-
ingly, there is a bias for specific exons in pancreas tissue.
This is not due to a bias in the number of ESTs/mRNAs
from mouse pancreatic tissue in the database since there
are as many pancreatic sequences as sequences from other
tissues like intestine or blood. Therefore, this is an inter-
esting result for which we do not have any explanations so
far.
As MIR SINEs were active prior to the mammalian diversi-
fication [29] it was unexpected to find 5 tissue-specific
MIR exonizations in human and only 1 in the mouse
genome. We examined the orthologous loci of the 5 rele-
vant genes RDH13, Elmo2, MRRF, Tri14 and
NP_060401.2 in the human and the mouse genome and
discovered that there is no MIR element in the mouse
genome in 4 of the 5 cases. Only for MRRF there is a MIR
in the mouse genome but the exonization in mouse is notBMC Genetics 2007, 8:78 http://www.biomedcentral.com/1471-2156/8/78
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Work flow of SERpredict Figure 3
Work flow of SERpredict. Programs and rules used for extracting tissue- or tumor-specific TE-containing exons, for details 
see Section "Work flow in SERpredict".
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Example output of SERpredict Figure 4
Example output of SERpredict. The output of SERpredict for [EMBL:AF466401] is presented. One of the isoforms shows a 
tumor-specific exon which was generated through the exonization of an Alu element.
SERpredict
Is the transposed element-containing isoform tissue- or tumor-specific?
Results for EMBL:AF466401
 
Gene id:  ENSG00000163374
Gene name:  YY1AP1
Gene description:  YY1-associated protein 1 (Hepatocellular carcinoma susceptibility protein)
Transcripts:  ENST00000355499 (11 Exons)
ENST00000359205 (10 Exons)
ENST00000347088 (10 Exons)
ENST00000368340 (10 Exons)
ENST00000295566 (11 Exons)
ENST00000361992 (10 Exons)
ENST00000354691 (10 Exons)
ENST00000368339 (10 Exons)
ENST00000361140 (11 Exons)
ENST00000311573 (10 Exons)
ENST00000361831 (12 Exons)
 
TE-exon Do the EST skip or hold the TE EST hits for tumor libraries EST hits for normal libraries
ENSE00001446920 holding 7 0
skipping 67 105
TE-exon LOD score NT NTprime NN NNprime
ENSE00001446920 3.15159293366765 67 7 105 0
Show legend  of the tabl e
  Genomic Information:
Transposed elements (TEs):
Source Information for each TE-exon:
Statistical analysis of tumor specificity:
Repeat 
family
Exon in which the transposed element occurs 
(Ensembl exon ID)
begin end contained in
AluJb ENSE00001446920 13 299 ENST00000361831
Alu-exon
download result in XML formatBMC Genetics 2007, 8:78 http://www.biomedcentral.com/1471-2156/8/78
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tissue-specific. For the specific exon of gene ST6galrsc4 in
the mouse genome, there is a MIR at the same position in
the human genome but the exon boundaries are different.
Therefore, the MIR is not exonized in the human genome. 
To show the efficiency of SERpredict, some of the genes
which we predicted to have a tissue-specific TE-derived
exon were verified by searching both the literature and the
database annotations. Isoform 2 of the T-cell activation
NFKB-like protein contains an Alu exon and was predicted
as ovary-specific (Table 3), which was verified through the
human SwissProt [30] entry Q9BRG9. A testis-specific iso-
form of TPK1 (Thiamine pyrophosphokinase 1) is
described in the OMIM [31] entry 606370 [32,33]. This
isoform is 100 bp longer than the broadly expressed vari-
ant. This complies with our results of an additional ERV1-
derived exon of about 100 bp which makes this isoform
testis-specific (Table 3). Additionally, the 4F2 cell-surface
heavy chain protein seems to be highly expressed in the
early stage of new bone formation [34]. Although we
found an alternative isoform expressed in bone (Table 3),
the specificity of the TE-derived exon is not described in
the literature and could therefore not be verified.
Our second analysis identified exons which were spliced
in a tumor-specific way. We found 21 such exons in
human and 2 in mouse genes. In the human genome, 11
were Alu exons, 1 was a L1 exon, 1 was a L2 exon and 4
were MIR exons, 3 were LTR exons and one exon derived
from a DNA transposon (see Table 5). In mouse, there was
1 L1 exon and 1 MIR exon (see Table 6). The data was fil-
tered to search for exons that were intronic within normal
tissues and were recognized as exons only within tumor-
ous tissues and, as such, could serve as potential markers
for tumor diagnostics. One such exon which contains an
Alu element was found in the human gene YY1AP1 (YY1-
associated protein 1: hepatocellular carcinoma suscepti-
bility protein). All results for TS > 85 and LOD > 2 are
given in Additional file 2 for the human and the mouse
genome.
We also found an indication for the accuracy of our pre-
dictions of genes with tumor-specific exons. From the
ST6GALNAC6 gene a 2.4 kB transcript has been described
for colon carcinoma, while in normal colon transcripts of
2.5 and 7.5 kB length are found [35,36]. The colon carci-
noma transcript could represent the isoform which omits
the first exon and contains the tumor-specific exon.
Taking these results into account, SERpredict is a useful
tool for analyzing TE insertions in genes and to determine
their effects for the human and mouse transcriptomes. On
the one hand, their insertion into mature mRNAs and the
subsequent change in the protein can cause effects in sin-
gle tissues or even cause major illnesses like cancer. This
has already been shown in several examples in the litera-
ture [10-12,15,17]. On the other hand, these new exons
could be raw material for future evolution of the organ-
isms. The new alternative TE-exons are only included into
a fraction of the transcripts of a gene while the rest of the
transcripts maintain their original function. Therefore, the
addition may be free to evolve with no loss of original
function. If the alternative form gains a useful function, its
splice sites are strengthened or it can become tissue-spe-
cific if the new function has only local benefits [14].
Table 1: Exonizations in the human genome
Human
Transposed element Alu L1 L2 CR1 MIR LTR DNA
Number of exonizations 432 88 40 4 86 119 90
Number of exonized transposed elements in the human genome which have a least three EST observations of the mRNA containing the TE exon. 
The Alu element is exonized most frequently among TEs.
Table 2: Exonizations in the mouse genome
Mouse
transposed element B1 B2 B4 L1 L2 ID MIR LTR DNA
number of exonizations 55 33 22 37 9 4 20 72 8
Number of exonized transposed elements in the mouse genome which have a least three EST observations of the mRNA containing the TE exon. 
The B1 element, which is homologous to the left arm of the Alu element, is exonized most frequently among mouse TEs.BMC Genetics 2007, 8:78 http://www.biomedcentral.com/1471-2156/8/78
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Table 4: Mouse tissue-specific TE-exons
Gene TE Chr. Tissue TS score
RIKEN cDNA 9830124H08 gene B1 14 pancreas 99.21
Gametogenetin binding protein 1 B1 17 pancreas 90.57
G protein-coupled receptor 177 B1 3 pancreas 98.05
Hydroxysteroid dehydrogenase like 2 B1 4 pancreas 98.44
NFKB inhibitor interacting Ras-like protein 1 B2 14 pancreas 96.48
RIKEN cDNA 4930444A02 gene B2 8 pancreas 92.81
ADP-ribosylation factor-like 4A B4 12 pancreas 93.75
Cyclin-dependent kinase 2 L2 10 pancreas 92.75
Target of EGR1. member 1 L2 4 limb 92.75
ST6 MIR 2 limb 92.74
intestine 99.4
Potentially tissue-specific TE-exons in the mouse transcriptome. From left to right: the gene name in which the exonization occurred, the 
transposed elements family name, the chromosome number, the name of the tissue to which the exon is specific and the TS score.
Table 3: Human tissue-specific TE-exons
Gene TE Chr. Tissue TS score
Zinc finger protein 195 L1 11 nerve 92.41
Zinc finger protein 33A L1 10 trachea 96.81
Ribonuclease P protein subunit p38 Alu 10 bone 92.30
AP-3 complex subunit mu-1 Alu 10 eye 99.21
Zinc finger protein 195. Alu 11 nerve 92.41
4F2 cell-surface  antigen heavy chain Alu 11 bone 96.69
uterus 96.34
Suppressor of G2 allele of SKP1 homolog Alu 13 pancreas 94.39
muscle 96.65
Centrosomal protein of 27 kDa Alu 15 uterus 93.29
Fumarylacetoacetate hydrolase domain-containing protein 1 Alu 16 placenta 94.01
T-cell activation NFKB-like protein Alu 19 ovary 93.65
Zinc finger protein 320 Alu 19 embryo 96.68
Zinc finger MYM-type protein 1 Alu 1 brain 97.84
Protein MANBAL Alu 20 stomach 93.75
Serine/threonine-protein kinase 6 Alu 20 mouth_oral 94.16
CDNA FLJ20699 fis. clone KAIA2372. Alu 22 muscle 93.75
brain 98.69
DNA directed RNA polymerase II Alu 7 colon 93.45
ovary 93.45
thymus 98.29
Putative ribosomal RNA methyltransferase 2 Alu 7 breast 93.74
GPI ethanolamine phosphate transf. 3 Alu 9 eye 91.82
Soluble calcium-activated nucl. 1 L2 17 placenta 98.14
Intraflagellar transport 20 homolog L2 17 colon 98.92
muscle 93.73
CDNA FLJ32655 fis CR1 17 testis 99.99
Retinol dehydrogenase 13 MIR 19 testis 93.74
uterus 92.69
Tripartite motif-containing protein 14. MIR 9 thymus 93.39
Salivary alpha-amylase precursor ERVK 1 muscle 97.67
Thiamin pyrophosphokinase 1 ERV1 7 testis 93.75
Hypothetical protein Q8WZ27 ERV1 4 thyroid 93.73
Trafficking protein particle complex protein 2 MER1 X testis 92.55
mTERF domain-containing protein 2. MER2 2 brain 99.09
Potentially tissue-specific TE-exons in the human transcriptome. From left to right: the gene name in which the exonization occurred, the 
transposed elements family name, the chromosome number, the name of the tissue to which the exon is specific and the TS score.BMC Genetics 2007, 8:78 http://www.biomedcentral.com/1471-2156/8/78
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Conclusion
Our results show that SERpredict produces relevant results,
demonstrating the importance of transposed elements in
shaping both the human and the mouse transcriptomes.
Due to the contribution of the primate-specific Alu ele-
ments, the effect of TEs on the human transcriptome is
several times higher than the effect on the mouse tran-
scriptome. We found some evidences for our results in
both the literature and the database annotations. Other
results still need biological verification. The pipeline can
therefore be used as an indicator for biologists interested
in tissue- or tumor-specific isoforms to decide which gene
might be interesting for further research.
Due to the incompleteness of the present gene databases,
our analysis remains confined to the annotated gene data.
With the continuous updating of the mRNA and EST data-
bases, and with it our internal MySQL database, the anal-
ysis can be repeated. This will make analyses more precise
and will provide results on previously undiscovered
exons, using SERpredict to obtain either tissue- or tumor-
specific splicing.
In further studies we will include additional organisms
into SERpredict in order to determine differences to the
human and mouse genomes. Additionally, we are plan-
ning to build a database containing the data of TE-con-
taining exons, the annotation with the TEs, as well as
tissue and tumor specificities for different organisms. This
will be an extension and an update of the AluGene data-
base [37,38].
Availability and requirements
Project name: SERpredict
Table 6: Mouse tumor-specific TE-exons
Gene TE Chr. LOD
Methylmalonic aciduria L1 8 2.76
ST6 MIR 2 2.56
Potentially tumor-specific TE-exons in the mouse transcriptome. From left to right: the gene name in which the exonization occurred, the 
transposed elements family name, the chromosome number and the LOD score.
Table 5: Human tumor-specific TE-exons
Gene TE Chr. LOD
Centrosomal protein of 27 kDa Alu 15 2.93
G-protein coupled receptor 56 precursor Alu 16 2.8
T-cell activation NFKB-like protein Alu 19 2.76
Dipeptidyl peptidase 9 Alu 19 3.49
NADH dehydrogenase Alu 19 2.07
YY1-associated protein 1 Alu 1 3.15
Centromere protein R Alu 1 2.74
Selenoprotein T precursor. Alu 3 2.64
Putative ribosomal RNA methyltransferase 2 Alu 7 2.4
GPI ethanolamine phosphate transferase 3 Alu 9 2.07
Protein RMI1 homolog. Alu 9 2.03
NHP2-like protein 1 L1 22 9.1
Zinc finger protein DZIP1 L2 13 2.34
Dynein light chain 2A. cytoplasmic MIR 20 4.43
Protein NipSnap1. MIR 22 6.55
ST6 MIR 9 2.69
Tripartite motif-containing protein 14. MIR 9 2.86
40S ribosomal protein SA ERV1 3 12.27
DNA directed RNA polymerase II MaLR 7 2.34
CDNA FLJ33708 fis, clone BRAWH2007862. MaLR 6 2.18
Beta-microseminoprotein precursor MER1 10 2.92
Potentially tumor-specific TE-exons in the human transcriptome. From left to right: the gene name in which the exonization occurred, the 
transposed elements family name, the chromosome number and the LOD score.BMC Genetics 2007, 8:78 http://www.biomedcentral.com/1471-2156/8/78
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Project home page: http://genius.embnet.dkfz-heidel
berg.de/menu/biounit/open-husar/
Operating system: Platform independent
Programming language: Perl; Other requirements:
Browser
License: NA
Any restrictions to use by non-academics: None
Usage
As part of the HUSAR open server, applications are listed
on the web page with additional information about the
tasks they perform. Query sequences can be uploaded by
the usual "copy & paste" procedure into the input box. If
more than one sequence is to be queried, a multiple
FASTA file can be used. The query starts by clicking on the
"submit" button and then the "run" button on the follow-
ing page. Results can be received by selecting the tab "Go
to results page". For further explanation, a flow chart, an
example output, and a test sequence are given on the web
page.
Input/output formats
SERpredict accepts only nucleotide sequences as input. For
output, see Section "Work flow in SERpredict".
Performance
Calculations are normally fast, depending on the length
of the input sequence and the number of exons the input
sequence contains. A calculation takes approximately one
minute.
Abbreviations
TE – transposed element, SINE – short interspersed ele-
ment, LINE – long interspersed element, MIR – mamma-
lian interspersed repeat, EST – expressed sequence tag, TS
score – tissue specificity score, LOD score – log-odd score,
HUSAR – Heidelberg Unix Sequence Analysis Resources
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